ASP5834
/ Astellas
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
August 20, 2025
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
(clinicaltrials.gov)
- P1 | N=364 | Recruiting | Sponsor: Astellas Pharma Inc | Not yet recruiting ➔ Recruiting
Enrollment open • Colorectal Cancer • Lung Cancer • Non Small Cell Lung Cancer • Oncology • Pancreatic Cancer • Solid Tumor • KRAS
1 to 1
Of
1
Go to page
1